Animal models of sepsis
MP Fink - Virulence, 2014 - Taylor & Francis
Sepsis remains a common, serious, and heterogeneous clinical entity that is difficult to
define adequately. Despite its importance as a public health problem, efforts to develop and …
define adequately. Despite its importance as a public health problem, efforts to develop and …
Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice
Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a
biologically active phospholipid mediator. Although PAF was initially recognized for its …
biologically active phospholipid mediator. Although PAF was initially recognized for its …
The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study
R Moreno, JL Vincent, R Matos, A Mendonca… - Intensive care …, 1999 - Springer
Objective: To evaluate the performance of total maximum sequential organ failure
assessment (SOFA) score and a derived measure, delta SOFA (total maximum SOFA score …
assessment (SOFA) score and a derived measure, delta SOFA (total maximum SOFA score …
Lipid mediators in inflammatory disorders
A Heller, T Koch, J Schmeck, K van Ackern - Drugs, 1998 - Springer
During the past few decades, intensive collaborative research in the fields of chronic and
acute inflammatory disorders has resulted in a better understanding of the pathophysiology …
acute inflammatory disorders has resulted in a better understanding of the pathophysiology …
Such stuff as dreams are made on: mediator-directed therapy in sepsis
JC Marshall - Nature reviews Drug discovery, 2003 - nature.com
Sepsis, a life-threatening disorder that arises through the body's response to infection, is the
leading cause of death and disability for patients in an intensive care unit. Advances in the …
leading cause of death and disability for patients in an intensive care unit. Advances in the …
Platelets in the immune response: revisiting platelet-activating factor in anaphylaxis
P Gill, NL Jindal, A Jagdis, P Vadas - Journal of Allergy and Clinical …, 2015 - Elsevier
Anaphylaxis is an acute, severe, life-threatening multisystem allergic reaction resulting from
the sudden systemic release of biochemical mediators and chemotactic substances …
the sudden systemic release of biochemical mediators and chemotactic substances …
The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses
CC Yost, AS Weyrich, GA Zimmerman - Biochimie, 2010 - Elsevier
The platelet-activating factor (PAF) signaling cascade evolved as a component of the
repertoire of innate host defenses, but is also an effector pathway in inflammatory and …
repertoire of innate host defenses, but is also an effector pathway in inflammatory and …
Lipid mediators in the pathophysiology of critical illness
EM Bulger, RV Maier - Critical care medicine, 2000 - journals.lww.com
Inflammatory lipid mediators are produced by the metabolism of membrane phospholipids
following a number of different stimuli. These mediators lead to a variety of cellular and …
following a number of different stimuli. These mediators lead to a variety of cellular and …
Leukocytes, the Janus cells in inflammatory disease
AK Nussler, UA Wittel, NC Nussler… - Langenbeck's archives of …, 1999 - Springer
Background: Leukocytes, also called white blood cells, can be categorized into three main
groups, granulocytes, monocytes, and lymphocytes, which can be further classified into …
groups, granulocytes, monocytes, and lymphocytes, which can be further classified into …
[HTML][HTML] The development of anti-inflammatory drugs for infectious diseases
Traditionally, disease is thought to result from an insufficient response of the host to
infection, leading to increased replication of microorganisms and consequently disease …
infection, leading to increased replication of microorganisms and consequently disease …